Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.Ann Surg Oncol. 2020; 27: 2269-2275https://doi.org/10.1245/s10434-020-08472-z
- Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer.J Surg Oncol. 2022; 125: 69-74https://doi.org/10.1002/jso.26756
- Clinical trials-Designing, implementing, and collaborating.J Surg Oncol. 2020; 122: 25-28https://doi.org/10.1002/jso.25889
- Clinical research in surgical oncology: an analysis of ClinicalTrials.gov.Ann Surg Oncol. 2013; 20: 3725-3731https://doi.org/10.1245/s10434-013-3054-y
- Analysis of Registered Clinical Trials in Surgical Oncology, 2008-2020.JAMA Netw Open. 2022; 5: e2145511https://doi.org/10.1001/jamanetworkopen.2021.45511
- Importance of surgeons in cooperative groups: Perspectives from the medical oncologists.J Surg Oncol. 2022; 125: 93-94https://doi.org/10.1002/jso.26754
- NIH Funding for Surgeon-Scientists in the US: What Is the Current Status?.J Am Coll Surg. 2021; 232: 265-274.e2https://doi.org/10.1016/j.jamcollsurg.2020.12.015
- Association of Surgeon Representation on NIH Study Sections With Receipt of Funding by Surgeon-scientists.Ann Surg. 2021; 273: 1042-1048https://doi.org/10.1097/sla.0000000000004836
- The Future of the surgeon-scientist: A Journey Funneled through inspiration, Roadblocks and Resilience.Ann Med Surg (Lond). 2021; 62: 65-67https://doi.org/10.1016/j.amsu.2020.12.047
- The Future of Basic Science in Academic Surgery: Identifying Barriers to Success for Surgeon-scientists.Ann Surg. 2017; 265: 1053-1059https://doi.org/10.1097/sla.0000000000002009
- Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical Trials.JAMA Netw Open. 2021; 4e2136577https://doi.org/10.1001/jamanetworkopen.2021.36577
- Investigator Responsibilities in Clinical Research. The Ochsner journal.Spring. 2020; 20: 44-49https://doi.org/10.31486/toj.19.0085
- Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.J Natl Cancer Inst. 2019; 111: 245-255https://doi.org/10.1093/jnci/djy221
- When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.J Natl Cancer Inst. 2021; 113: 244-257https://doi.org/10.1093/jnci/djaa155
- Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.J Clin Med. 2022; : 11https://doi.org/10.3390/jcm11102840
- Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2021; 19: 329-359https://doi.org/10.6004/jnccn.2021.0012
- of Prescribing Information, ONYVIDE (liposomal irinotecan) for injection.Drugs@FDA. 2015; : 1-18
- Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.Clin Cancer Res. 2000; 6: 2012-2020
- Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion.Cancer Res. 2014; 74: 7003-7013https://doi.org/10.1158/0008-5472.Can-14-0572
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.Lancet. 2016; 387: 545-557https://doi.org/10.1016/s0140-6736(15)00986-1
- Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.Anticancer Res. 2017; 37: 5553-5558https://doi.org/10.21873/anticanres.11987
- Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.Clin Pharmacol Ther. 2017; 102: 997-1005https://doi.org/10.1002/cpt.720
- Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial.Ann Surg Oncol. 2017; 24: 1916-1922https://doi.org/10.1245/s10434-017-5814-6
- Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.Anticancer Drugs. 2017; 28: 1086-1096https://doi.org/10.1097/cad.0000000000000545
- Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience.Med Oncol. 2019; 36: 87https://doi.org/10.1007/s12032-019-1309-6
- Designing clinical research.4 edition. Lippincott Williams and Wilkins, 2013
- The FDA's Drug Review Process: Ensuring Drugs Are Safe and Effective.
- Understanding implementability in clinical trials: a pragmatic review and concept map.Trials. 2021; 22: 232https://doi.org/10.1186/s13063-021-05185-w
- Understanding the Use of Composite Endpoints in Clinical Trials.West J Emerg Med. 2018; 19: 631-634https://doi.org/10.5811/westjem.2018.4.38383
- Increasing operational and scientific efficiency in clinical trials.Br J Cancer. 2020; 123: 1207-1208https://doi.org/10.1038/s41416-020-0990-8
- Pancreas cancer trials for early stage disease: Surgeons leading therapeutic cooperative group trials.J Surg Oncol. 2022; 125: 75-83https://doi.org/10.1002/jso.26701
- Industry sponsorship and research outcome.Cochrane Database Syst Rev. 2017; 2Mr000033https://doi.org/10.1002/14651858.MR000033.pub3
- Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT).BMC Med Res Methodol. 2021; 21: 182https://doi.org/10.1186/s12874-021-01359-x
- Changing Trends in Industry Funding for Surgical Oncologists.Ann Surg Oncol. 2019; 26: 2327-2335https://doi.org/10.1245/s10434-019-07380-1
- Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.Inflamm Bowel Dis. 2017; 23: 14-22https://doi.org/10.1097/mib.0000000000000907
- Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.J Clin Med. 2018; 7: 567https://doi.org/10.3390/jcm7120567
- Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.Ann Surg Oncol. 2014; 21: 1501-1505https://doi.org/10.1245/s10434-013-3061-z
- Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.J Oncol Pract. 2013; 9: e275-e283https://doi.org/10.1200/jop.2013.001120
- Barriers to participation in clinical trials: a physician survey.Curr Oncol. 2018; 25: 119-125https://doi.org/10.3747/co.25.3857
- Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.Ann Surg Oncol. 2015; 22: 3174-3183
- Patient-level costs in margin re-excision for breast-conserving surgery.Br J Surg. 2019; 106: 384-394
- Predictors of margin status after breast-conserving operations in an underscreened population.Langenbecks Arch Surg. 2013; 398: 455-462
- Opportunities to reduce reoperations and to improve inter-facility profiling after initial breast-conserving surgery for cancer. A report from the NCDB.Eur Surg Oncol. 2019; 45: 2026-2036
- Hepatic artery infusion pumps.Journal of Surgical Oncology. 2020; 1: 70-77
Article info
Publication history
Published online: November 03, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
